Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/30/2003US20030203464 Comprise Gtpase (RAC-GEF) polypeptide for treating diagnosis and treatment of cell proliferative disorders; antiproliferative agents
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203451 Interleukin-17 (IL-17)/G-protein coupled receptors protein for use in diagnosis and treatment of cell proliferative, bone and inflammatory disorders
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203436 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203409 Comprises monoclonal antibody for detection, diagnosis and treatment of cell proliferation disorders
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203383 Novel neurotrophic factor immunoassays
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203355 Preparing such binding ligands and libraries, and methods of identifying a binding ligand that specifically binds to a target molecule
10/30/2003US20030202987 Hepatitis virus; oligomer protein
10/30/2003US20030202980 Methods and reagents for decreasing clinical reaction to allergy
10/30/2003US20030202977 Antiinflammatory agents
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202975 Using monoclonal antibodies; shrinkage of solid tumors
10/30/2003US20030202973 Treatment of refractory human tumors with epidermal growth factor receptor and HER1 mitogenic ligand (EGFRML) antagonists
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482863A1 Universal libraries for immunoglobulins
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482607A1 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
10/30/2003CA2482596A1 Antibodies specific for mucin polypeptide
10/30/2003CA2482368A1 Cytokine receptor
10/30/2003CA2481507A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003CA2481401A1 Antibodies that specifically bind to tl5
10/30/2003CA2481085A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/29/2003EP1357189A2 Elicitor of the hypersensitive response in plants
10/29/2003EP1357132A2 Detection of the her2 receptor by means of biotinylated humanized antibody
10/29/2003EP1357131A2 Treatment of lupus nephritis with anti-CD4OL compounds
10/29/2003EP1356829A2 Preparation of virally inactivated intravenously injectable immune serum globulin
10/29/2003EP1356824A2 88KDA tumorigenic growth factor and antagonists
10/29/2003EP1356820A1 DNA vaccine combined with an inducer of tumor cell apoptosis
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356298A2 Diagnosis and treatment of disease
10/29/2003EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356110A2 Non-invasive method for detecting target rna
10/29/2003EP1356108A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356093A2 Gene markers for lung cancer
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356075A2 Protein scaffolds for antibody mimics and other binding proteins
10/29/2003EP1356052A2 Prokaryotically produced antibodies and uses thereof
10/29/2003EP1356051A2 Genes
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1355950A1 Antibodies for human cytochrome p450 2d6
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355948A1 Materials and methods for treatment of hepatitis c
10/29/2003EP1355947A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
10/29/2003EP1355946A1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355933A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases
10/29/2003EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP1355917A2 Compositions and methods relating to breast specific genes and proteins
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
10/29/2003EP0996728B1 IMPROVED ANTI-IgE ANTIBODIES AND METHODS OF IMPROVING ANTIBODIES
10/29/2003EP0920501B1 Neuritin, a neurogene
10/29/2003EP0745128B1 Hepatitis b virus mutants, reagents and methods for detection
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003EP0682710B1 Isolation process using immobilized proteins with specific binding capacities
10/29/2003EP0627000B1 Mammalian expression systems for hcv proteins
10/29/2003EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
1 ... 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 ... 1494